ATNM icon

Actinium Pharmaceuticals
ATNM

Overview Fund Activity

55 hedge funds and large institutions have $21.1M invested in Actinium Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+6
Holders Change %
+12.24%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
8
Closed
5
Calls
$3.44M
Puts
$2.23M
Net Calls
+$1.22M
Net Calls Change
-$611K

Top Buyers

1
JGC
1
J. Goldman & Co
New York
$1.1M
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$867K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.58M
4
Simplex Trading
4
Simplex Trading
Illinois
$294K
5
Group One Trading
5
Group One Trading
Illinois
$533K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$90K
2
Two Sigma Investments
2
Two Sigma Investments
New York
$117K
3
VF
3
Virtu Financial
New York
$93K
4
CSS
4
Cubist Systematic Strategies
Connecticut
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$303K
Name Holding Trade Value Shares
Change 		Shares
Change %
TSS
51
Two Sigma Securities
New York
– -$61K -12,624 Closed
BCV
52
Banque Cantonale Vaudoise
Switzerland
– -$1K -309 Closed
CAPTRUST Financial Advisors
53
CAPTRUST Financial Advisors
North Carolina
– -$1K -166 Closed
1 2
3